Title: Synthetic analogs for the study of GABA as a neurotransmitter
Abstract: Medicinal Research ReviewsVolume 3, Issue 2 p. 91-118 Article Synthetic analogs for the study of GABA as a neurotransmitter Robin D. Allan, Robin D. Allan Department of Pharmacology, University of Sydney, NSW, 2006, AustraliaSearch for more papers by this authorGraham A. R. Johnston, Graham A. R. Johnston Department of Pharmacology, University of Sydney, NSW, 2006, AustraliaSearch for more papers by this author Robin D. Allan, Robin D. Allan Department of Pharmacology, University of Sydney, NSW, 2006, AustraliaSearch for more papers by this authorGraham A. R. Johnston, Graham A. R. Johnston Department of Pharmacology, University of Sydney, NSW, 2006, AustraliaSearch for more papers by this author First published: April/June 1983 https://doi.org/10.1002/med.2610030202Citations: 55AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 G. A. R. Johnston, D. R. Curtis, W. C. De Groat, and A. W. Duggan, Biochem. Pharmacol., 17, 2488 (1968). 2 P. Krogsgaard-Larsen, L. Brehm, and K. Schaumburg, Acta Chem. Scand. Ser. B, 35, 311 (1981). 3 D. R. Curtis and G. A. R. Johnston, in Neuropoisons, Vol. 2, L. L. Simpson and D. R. Curtis, Eds., Plenum, New York, 1974, p. 207. 4 G. A. R. Johnston, in Receptors in Pharmacology, J. R. Smythies and R. J. Bradley, Eds., Marcel Dekker, New York, 1978, p. 295. 5 G. A. R. Johnston, in GABA in Nervous System Function, E. Roberts, T. N. Chase, and D. B. Tower, Eds., Raven, New York, 1976, p. 395. 6 G. A. R. Johnston, R. D. Allan and J. H. Skerritt, in Handbook of Neurochemistry, A. Lajtha, Ed., Plenum, New York, 1983, in press. 7 G. A. R. Johnston, Ann. Rev. Pharmacol. Toxicol., 18, 269 (1978). 8 P. Krogsgaard-Larsen and A. V. Christensen, Ann. Rep. Med. Chem., 15, 41 (1980). 9 P. Krogsgaard-Larsen and E. Falch, Mol. Cell. Biochem., 38, 129 (1981). 10 L. L. Iversen, in Psychopharmacology: A Generation of Progress, M. A. Lipton, A. DiMascio, and K. F. Killam, Eds., Raven, New York, 1978, p. 25. 11 S. J. Enna and A. Maggi, Biochem. Pharmacol., 24, 1727 (1979). 12 S. J. Enna, Biochem. Pharmacol., 30, 907 (1981). 13 S. J. Enna, in Neuropharmacology of Central and Behavioral Disorders, G. Palmer, Ed., Academic, New York, 1982, in press. 14 A. Nistri and A. Constanti, Prog. Neurobiol., 13, 117 (1979). 15 D. R. Curtis and G. A. R. Johnston, Rev. Physiol. 69, 97 (1974). 16 N. G. Bowery, D. R. Hill, A. L. Hudson, A. Doble, D. N. Middlemiss, J. Shaw, and M. Turnbull, Nature, 283, 92 (1980). 17 D. R. Hill and N. G. Bowery, Nature (London), 290, 149 (1981). 18 N. G. Bowery, A. Doble, D. R. Hill, A. L. Hudson, J. S. Shaw, M. J. Turnbull, and R. Warrington, Eur. J. Pharmacol., 71, 53 (1981). 19 J. R. Cooper, F. E. Bloom, and R. H. Roth, The Biochemical Basis of Neuropharmacology, Oxford University Press, New York, 1978, p. 244. 20 G. A. R. Johnston, Proc. Aust. Physiol. Pharmac. Soc., 9, 94 (1978). 21 P. M. Beart, M. L. Uhr, and G. A. R. Johnston, J. Neurochem., 19, 1849 (1972). 22 A. Karlsson, F. Fonnum, D. Malthe-Sorenssen, and J. Storm-Mathisen, Biochem. Pharmac., 23, 3053 (1974). 23 L. P. Davies, G. A. R. Johnston, and A. L. Stephanson, J. Neurochem., 25, 387 (1975). 24 M. J. W. Brennan, R. C. Cantrill, M. Oldfield, and P. Krogsgaard-Larsen, Mol. Pharmacol., 19, 27 (1981). 25 J. S. Kelly, in Handbook of Psychopharmacology, Vol. 2, L. L. Iversen, S. D. Iversen and S. H. Snyder, Eds., Plenum, New York, 1975, p. 29. 26 A. Nistri and A. Constanti, Prog. Neurobiol., 13, 117 (1979). 27 Y. Kudo, Prog. Neurobiol., 11, 1 (1978). 28 S. J. Enna and S. H. Snyder, Brain Res., 100, 81 (1975). 29 R. W. Olsen, M. K. Ticku, D. Greenlee, and P. Van Ness, in GABA-Neurotransmitters, P. Krogsgaard-Larsen, J. Scheel-Kruger, and H. Kofod, Eds., Munksgaard, Copenhagen, 1979, p. 165. 30 P. Krogsgaard-Larsen and G. A. R. Johnston, J. Neurochem., 30, 1377 (1978). 31 G. A. R. Johnston and M. Willow, Trends Pharmac., 3, 328 (1982). 32 J. H. Skerritt, M. Willow, and G. A. R. Johnston, Neurosci. Lett. 29, 63 (1982). 33 D. R. Curtis and J. C. Watkins, Pharmacol. Rev., 17, 347 (1965). 34 A. Krantis and D. I. B. Kerr, Naunyn-Schmiedebergs Arch. Pharmakol., 317, 257 (1981). 35 A. Krantis, M. Costa, J. B. Furness, and J. Orback, Eur. J. Pharmacol., 67, 461 (1980). 36 N. Anwar and D. F. J. Mason, Br. J. Pharmacol., 75, 177 (1982). 37 A. Schousboe, P. Thorbek, L. Hertz, and P. Krogsgaard-Larsen, J. Neurochem., 33, 181 (1979). 38 P. M. Beart, G. A. R. Johnston, and M. L. Uhr, J. Neurochem., 19, 1885 (1972). 39 K. Tomita, Tetrahedron Lett., 2587 (1971). 40 K. Tanaka, H. Akutsu, Y. Ozaki, Y. Kyogoku, and K. Tomita, Bull. Chem., Soc. Jph., 51, 2654 (1978). 41 P. R. Andrews and G. A. R. Johnston, Biochem. Pharmacol., 28, 2697 (1979). 42 A. F. Casy, in Progress in Medicinal Chemistry, Vol. 11, G. P. Ellis, and G. B. West, Eds., North-Holland, Amsterdam, 1975, p. 1. 43 M. Segal, K. Sims, and E. Smissman, Br. J. Pharmacol., 54, 181 (1975). 44 R. A. Nicoll, Br. J. Pharmacol., 59, 303 (1977). 45 L. L. Iversen and G. A. R. Johnston, J. Neurochem., 18, 1939 (1971). 46 P. M. Beart and G. A. R. Johnston, J. Neurochem., 20, 319 (1973). 47 F. Schon and J. S. Kelly, Brain Res., 66, 289 (1974). 48 F. Schon and J. S. Kelly, Brain Res., 86, 243 (1975). 49 P. M. Beart and G. A. R. Johnston, Brain Res., 49, 459 (1973). 50 N. G. Bowery and D. A. Brown, Br. J. Pharmacol., 50, 205 (1974). 51 A. Galli, L. Zilletti, M. Scotton, G. Adembri, and A. Giotti, Pharmacol. Res. Commun., 12, 267 (1980). 52 E. Roberts in Advances in Pharmacology and Therapeutics, Vol. 2: Neurotransmitters, J. R. Boisser, P. Lechat and J. Fichelle, Eds., Pergamon, Oxford, 1978, p. 43. 53 H. Hjeds and T. Honore, Acta Chem. Scand. Ser. B, 32, 187 (1978). 54 R. C. A. Frederickson, M. Neuss, S. L. Morzorati, and W. J. McBride, Brain Res., 145, 117 (1978). 55 L. J. Fowler and R. A. John, Biochem. J., 130, 569 (1972). 56 L. J. Fowler, J. Neurochem., 21, 437 (1973). 57 W. Loscher, Arch. Pharmacol., 315, 119 (1980). 58 R. J. Breckenridge, S. H. Nicholson, A. J. Nicol, C. J. Suckling, B. Leigh, and L. L. Iversen, J. Neurochem., 37, 837 (1981). 59 R. J. Breckenridge, S. H. Nicholson, A. J. Nicol, and C. J. Suckling, Biochem. Pharmacol., 30, 3045 (1981). 60 H. H. Frey and W. Loscher, Neuropharmacol., 19, 217 (1980). 61 M. N. Perkins and T. W. Stone, Br. J. Pharmacol., 75, 93 (1982). 62 P. Forster, H. G. E. Lloyd, P. Morgan, M. Parker, M. N. Perkins, and T. W. Stone, Br. J. Pharmac., 74, 274P (1981). 63 L. P. Davies, J. W. Hambley, and G. A. R. Johnston, Neurosci. Lett., 29, 57 (1982). 64 E. G. McGeer, P. L. McGeer, and H. McLennan, J. Neurochem., 8, 36 (1961). 65 E. Buehler and G. B. Brown, J. Org. Chem., 32, 265 (1967). 66 L. Galazigna, L. Garbin, M. Bianchi and A. Marzotto, Arch. Int. Pharmacodyn. Ther., 235, 73 (1978). 67 N. M. Van Gelder, J. Neurochem., 16, 1355 (1969). 68 E. L. Schumann, L. A. Paquette, R. V. Heinzelman, D. P. Wallach, J. P. Da Vanzo, and M. E. Greig, J. Med. Chem., 5, 464 (1962). 69 G. A. R. Johnston and V. J. Balcar, J. Neurochem., 22, 609 (1974). 70 S. H. Nicholson, C. J. Suckling, and L. L. Iversen, J. Neurochem., 32, 249 (1979). 71 G. A. R. Johnston, R. D. Allan, B. Twitchin, and S. M. E. Kennedy, unpublished results. 72 G. A. R. Johnston, R. D. Allan, S. M. E. Kennedy, and B. Twitchin, in GABA-Neurotransmitters, P. Krogsgaard-Larsen, J. Scheel-Kruger, and H. Kofod, Eds., Munksgaard, Copenhagen, 1978, p. 149. 73 G. Tunnicliff, T. T. Ngo and A. Barbeau, Experientia, 33, 20 (1977). 74 D. R. Curtis, C. J. A. Game, G. A. R. Johnston, and R. M. McCulloch, Brain Res., 70, 493 (1974). 75 J. Davies and J. C. Watkins, Brain Res., 70, 501 (1974). 76 B. Ault and R. H. Evans, Eur. J. Pharmacol., 71, 357 (1981). 77 S. J. Potashner, J. Neurochem., 32, 103 (1979). 78 G. A. R. Johnston, M. H. Hailstone, and C. G. Freeman, J. Pharm. Pharmacol., 32, 230 (1980). 79 K. Saito, S. Konishi, and M. Otsuka, Brain Res., 97, 177 (1975). 80 N. T. Buu and N. M. Van Gelder, Br. J. Pharmacol., 52, 401 (1974). 81 L. L. Iversen and J. S. Kelly, Biochem. Pharmacol., 24, 933 (1975). 82 G. A. R. Johnston and B. Twitchin, Br. J. Pharmacol., 59, 218 (1977). 83 R. Roskoski, J. Neurochem., 36, 544 (1981). 84 G. A. R. Johnston and B. Twitchin, unpublished results. 85 E. Roberts, D. N. Krause, E. Wong, and A. Mori, J. Neuroscience, 1, 132 (1981). 86 A. Galli, L. Zilletti, M. Scotton, G. Adembri, and A. Giotti, J. Neurochem., 32, 1123 (1979). 87 A. Schousboe, P. Thorbek, L. Hertz, and P. Krogsgaard-Larsen, J. Neurochem., 33, 181 (1979). 88 T. Honore, H. Hjeds, P. Krogsgaard-Larsen, and T. R. Christiansen, Eur. J. Med. Chem., 13, 429 (1978). 89 J. B. Nielands, A. Neuberger, and J. J. Scott, J. Am. Chem. Soc., 82, 214 (1960). 90 V. A. Percy, M. C. L. Lamm, and J. J. F. Taljaard, J. Neurochem., 36, 69 (1981). 91 M. Kinuta, Biochim. Biophys. Acta, 542, 56 (1978). 92 J. Kollonitsch, S. Marburg, and L. M. Perkins, J. Org. Chem., 44, 771 (1979). 93 G. A. R. Johnston, D. R. Curtis, P. M. Beart, C. J. A. Game, R. M. McCulloch, and B. Twitchin, J. Neurochem., 24, 157 (1975). 94 P. M. Beart, D. R. Curtis, and G. A. R. Johnston, Nature, 234, 80 (1971). 95 R. D. Allan and B. Twitchin, Aust. J. Chem., 31, 2283 (1978). 96 R. D. Allan, Aust. J. Chem., 32, 2507 (1979). 97 R. D. Allan, G. A. R. Johnston, and B. Twitchin, Aust. J. Chem., 33, 1115 (1980). 98 B. W. Metcalf, Biochem. Pharmacol., 28, 1705 (1979). 99 M. J. Jung, B. Lippert, B. W. Metcalf, P. Schechter, J. Bohlem, and A. Sjoerdsma, J. Neurochem., 28, 717 (1977). 100 P. Bey, M. J. Jung, F. Gerhart, D. Schirlin, V. Van Dorsselaer, and P. Casara, J. Neurochem., 37, 1341 (1981). 101 R. B. Silvermann and M. A. Levy, Biochem. Biophys. Res. Commun., 95, 250 (1980). 102 G. Bartholini, B. Scatton, B. Zivkovic, and K. G. Lloyd, in GABA-Neurotransmitters, P. Krogsgaard-Larsen, J. Scheel-Kruger and H. Kofod, Eds., Munksgaard, Copenhagen, 1979, p. 326. 103 M. Desarmenien, P. Feltz, P. M. Headley, and F. Santangelo, Br. J. Pharmacol., 72, 355 (1981). 104 R. D. Allan, D. R. Curtis, P. M. Headley, G. A. R. Johnston, D. Lodge, and B. Twitchin, J. Neurochem., 34, 652 (1980). 105 J. P. O'Donnell, D. A. Johnston, and A. J. Azzaro J. Med. Chem., 23, 1142 (1980). 106 J. G. Cannon and J. E. Garst, J. Org. Chem., 40, 182 (1975). 107 H. R. Kricheldorf and W. Regel, Chem. Ber., 106, 3753 (1973). 108 R. D. Allan, D. R. Curtis, P. M. Headley, G. A. R. Johnston, S. M. E. Kennedy, D. Lodge, and B. Twitchin. Neurochem. Res., 5, 393 (1980). 109 R. J. Hitzemann and H. L. Loh, Brain Res., 144, 63 (1978). 110 R. D. Allan, G. A. R. Johnston and B. Twitchin. Aust. J. Chem., 32, 2517 (1979). 111 G. A. R. Johnston, R. D. Allan, P. R. Andrews, S. M. E. Kennedy, and B. Twitchin, in Advances in Pharmacology and Therapeutics, Vol.2: Neurotransmitters, P. Simon, Ed., Pergamon, Oxford, 1978, p. 11. 112 R. D. Allan, R. H. Evans, and G. A. R. Johnston, Br. J. Pharmacol, 70, 609 (1980). 113 R. D. Allan, G. A. R. Johnston, and B. Twitchin, Aust. J. Chem., 33, 599 (1980). 114 N. G. Bowery, G. P. Jones, and M. J. Neal, Nature, 264, 284 (1976). 115 R. D. Allan, G. A. R. Johnston, and B. Twitchin, Aust. J. Chem., 34, 2231 (1981). 116 H. Mishima and H. Kurihara, Tetrahedron Lett., 17, 537 (1976). 117 R. D. Allan, G. A. R. Johnston, and B. Twitchin, Neuroscience Lett., 4, 51 (1977). 118 R. R. Rando and F. W. Bangerter, J. Am. Chem. Soc., 99, 5141 (1977). 119 S. Danishefsky and F. M. Hershenson, J. Org. Chem., 44, 1180 (1979). 120 B. W. Metcalf and M. J. Jung, Mol. Pharmacol., 16, 539 (1979). 121 D. T. Witiak, K. Tomita and R. J. Patch, J. Med. Chem., 24, 788 (1981). 122 R. M. Black, J. Chem. Soc. Perkin Trans. 1, 73 (1982). 123 K. Biziere, F. Huguet, G. Narcisse and M. Breteau, Eur. J. Pharmacol., 75, 167 (1981). 124 P. Thorbek, H. Hjeds and K. Schaumburg, Acta Chem. Scand. Ser. B, 35, 473 (1981). 125 R. Allan, Tetrahedron Lett., 19, 2199 (1978). 126 P. D. Kennewell, S. S. Matharu, J. B. Taylor, and P. G. Sammes, J. Chem. Soc. Perkin Trans. 1, 2542 (1980). 127 G. A. R. Johnston, P. Krogsgaard-Larsen, A. L. Stephanson, and B. Twitchin, J. Neurochem., 26, 1029 (1976). 128 G. A. R. Johnston, A. L. Stephanson and B. Twitchin, J. Pharm. Pharmacol., 29, 240 (1977). 129 P. Jacobsen, K. Schaumburg, J. Larsen and P. Krogsgaard-Larsen, Acta Chem. Scand. Ser. B, 35, 298 (1981). 130 P. Krogsgaard-Larsen, P. Jacobsen, L. Brehm, J. Larsen, and K. Schaumburg, Eur. J. Med. Chem., 15, 529 (1980). 131 P. Jacobsen, K. Schaumburg, J. Larsen, and P. Krogsgaard-Larsen, Acta Chem. Scand. Ser. B, 35, 233 (1981). 132 P. Krogsgaard-Larsen, E. Falch, A. Schousboe, D. R. Curtis, and D. Lodge, J. Neurochem., 34, 756 (1980). 133 G. A. R. Johnston, P. Krogsgaard-Larsen, and A. L. Stephenson, Nature, 258, 627 (1975). 134 P. Krogsgaard-Larsen, G. A. R. Johnston, D. Lodge, and D. R. Curtis, Nature, 268, 53 (1977). 135 P. Krogsgaard-Larsen and T. Roldskov-Christiansen, Eur. J. Med. Chem., 14, 157 (1979). 136 P. Krogsgaard-Larsen, H. Hjeds, D. R. Curtis, D. Lodge, and G. A. R. Johnston, J. Neurochem., 32, 1717 (1979). 137 D. R. Curtis, A. W. Duggan, D. Felix, and G. A. R. Johnston, Brain Res., 32, 69 (1971). 138 P. Krogsgaard-Larsen, G. A. R. Johnston, D. R. Curtis, C. J. A. Game, and R. M. McCulloch, J. Neurochem., 25, 803 (1975). 139 R. C. Hill, R. Maurer, H. Buescher, and D. Roemer, Eur. J. Pharmacol., 69, 221 (1981). 140 J. Arnt and P. Krogsgaard-Larsen, Brain Res., 117, 395 (1979). 141 N. G. Bowery and G. P. Jones, Br. J. Pharmacol., 56, 323 (1976). 142 J. M. Godfraind, K. Krnjevic, H. Maretic, and R. Pumain, Can. J. Physiol. Pharmacol., 51, 790 (1973). 143 R. H. Evans, A. A. Francis, K. Hunt, M. R. Martin, and J. C. Watkins, J. Pharm. Pharmacol., 30, 363 (1978). 144 J. G. Atkinson, Y. Girard, J. Rokach, and C. S. Rooney, J. Med. Chem., 22, 99 (1979). 145 S. J. Enna, J. F. Collins, and S. H. Snyder, Brain Res., 124, 185 (1977). 146 H. Möhler and T. Okada, Mol. Pharmacol., 14, 256 (1978). 147 M. K. Ticku, M. Bann, and R. W. Olsen, Mol. Pharmacol., 14, 391 (1978). 148 R. W. Olsen, J. Leeb-Lundberg, and C. Napias, Brain Res. Bull., 5(Suppl. 2), 217 (1980). 149 R. W. Olsen, J. Neurochem., 37, 1 (1981). 150 E. J. Corey and H. L. Pearce, J. Am. Chem. Soc., 101, 5841 (1979). 151 N. G. Bowery, J. F. Collins, and R. G. Hill, Nature, 261, 601 (1976). 152 N. G. Bowery, D. A. Brown, and J. F. Collins, Br. J. Pharmacol., 53, 422 (1975). Citing Literature Volume3, Issue2April/June 1983Pages 91-118 ReferencesRelatedInformation
Publication Year: 1983
Publication Date: 1983-04-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 62
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot